These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 5776720

  • 1. [Hazards of thromboembolism during the use of ovulation inhibitors].
    Döring GK.
    Dtsch Med Wochenschr; 1969 Apr 18; 94(16):867-8. PubMed ID: 5776720
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of ovulation inhibitors on the visual organ].
    Thiel HL.
    Klin Monbl Augenheilkd; 1969 Jun 18; 154(6):845-7. PubMed ID: 5354449
    [No Abstract] [Full Text] [Related]

  • 3. [May ovulation inhibitors be used without hesitation in the post-thrombotic syndrome?].
    Graeff H, von Hugo R, Kuhn W, Ludwig H.
    Med Welt; 1979 Apr 06; 30(14):507-8. PubMed ID: 431388
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Report of the committee set up by the executive of the Irish Medical Association to advise on the hazards and side-effects of ovulation suppressants.
    Ir Med J; 1978 Feb 17; 17(2 Suppl):1-10. PubMed ID: 640807
    [No Abstract] [Full Text] [Related]

  • 6. [Fatal thrombotic complication following the intake of ovulation inhibitors (case report)].
    Ring J, Khaler J, Konopka P, Fischer H.
    Geburtshilfe Frauenheilkd; 1971 Nov 17; 31(11):1090-3. PubMed ID: 5159215
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Oral contraceptives and mesenteric thromboembolism].
    Lauritsen JG.
    Ugeskr Laeger; 1968 Aug 15; 130(33):1348-9. PubMed ID: 5701090
    [No Abstract] [Full Text] [Related]

  • 9. [Risk of thromboembolism with oral contraceptives].
    Haeger K, Nilsson IM, Robertson B.
    Lakartidningen; 1967 Sep 06; 64(36):3498-504. PubMed ID: 5597076
    [No Abstract] [Full Text] [Related]

  • 10. [Arterial occlusions due to adverse effects of oral ovulation inhibitors].
    Redenbacher M, Krauss J.
    Z Allgemeinmed; 1971 May 31; 47(15):811-5. PubMed ID: 5088746
    [Abstract] [Full Text] [Related]

  • 11. [Letter: Thrombosis hazards due to estrogen dosage].
    Lauritzen C.
    Med Welt; 1974 May 17; 25(20):919-20. PubMed ID: 4845129
    [No Abstract] [Full Text] [Related]

  • 12. [Post aut propter? Coronary thrombosis and venous thromboembolism following long-term use of oral contraceptives].
    Visser J.
    Ned Tijdschr Geneeskd; 1967 Apr 29; 111(17):796. PubMed ID: 6047447
    [No Abstract] [Full Text] [Related]

  • 13. [On the modification of serum lipids in healthy women using ovulation inhibitors. I].
    Burger H, Florian HJ, Holzmann G.
    Z Geburtshilfe Gynakol; 1969 Apr 29; 170(1):1-14. PubMed ID: 5794758
    [No Abstract] [Full Text] [Related]

  • 14. Thromboembolism and oral contraceptives.
    Gilder SS.
    Can Med Assoc J; 1968 Oct 12; 99(14):726-7. PubMed ID: 5700690
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Are oral contraceptives safe?
    Coyle TF.
    Aust Fam Physician; 1998 Jul 12; 27(7):578. PubMed ID: 9679374
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral contraceptives and venous thromboembolism.
    Skegg D.
    N Z Med J; 2000 Sep 08; 113(1117):385. PubMed ID: 11050907
    [No Abstract] [Full Text] [Related]

  • 20. Oral contraceptives and venous thromboembolism: acquired APC resistance?
    Schramm W, Heinemann LA.
    Br J Haematol; 1997 Aug 08; 98(2):491-2. PubMed ID: 9266957
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.